Cancer remains one of humanity's most formidable foes, but the battle is far from over. The American Society of Clinical Oncology (ASCO) is gearing up to shake things up in 2026 with its Breakthrough meeting, and they want you to be part of it. But here's where it gets exciting: for the first time ever, this pivotal event will take place in Singapore, bringing together the brightest minds in oncology from across the globe. And this is the part most people miss—it's not just about presenting research; it's about accelerating progress and turning groundbreaking science into real-world solutions.
ASCO has officially opened the call for abstracts, inviting researchers worldwide to submit their most innovative oncology studies. From artificial intelligence to breast cancer treatments, the scope is vast, and the potential impact is even greater. Submissions are open now until 11:59 PM Eastern Time on February 24, 2026 (that's 12:59 PM Singapore Standard Time on February 25, 2026). The meeting itself will run from June 25-27, 2026, co-hosted by ASCO, the Singapore Society of Oncology, and other leading societies in the Asia Pacific region.
But here's the controversial part: While Asia is poised to lead the charge in global oncology, some argue that regional disparities in healthcare systems could hinder collaboration. What do you think? Can Asia truly drive the future of cancer care, or are there systemic barriers that need addressing first? Let’s debate this in the comments!
For researchers, this is more than just a conference—it’s a platform to showcase cutting-edge data, engage with international experts, and forge collaborations that could fast-track treatments from lab to patient. As Dr. Yun Yen, Program Committee Chair, puts it, 'ASCO Breakthrough is where science meets real-world impact. It’s an opportunity to amplify good science into real momentum.'*
Accepted abstracts will be published in the Journal of Clinical Oncology supplement, and professionals from Low- and Middle-Income Countries (LMICs) can apply for fee waivers. Last year’s meeting in Yokohama drew 790 experts from over 35 countries, and 2026 promises to be even bigger. Registrations open in December 2025, so mark your calendars!
To submit your abstract or learn more, visit breakthrough.asco.org.
About ASCO: Founded in 1964, ASCO is a global leader in the fight against cancer, representing over 50,000 oncology professionals. Through research, education, and advocacy, ASCO is working toward a world where cancer is preventable, curable, or manageable. Learn more at www.ASCO.org and follow them on social media for the latest updates.
About ASCO Breakthrough: This annual Asia-Pacific meeting is a hub for novel research, multidisciplinary insights, and technological advancements in cancer care. Whether you're presenting an abstract, participating in case discussions, or networking with peers, ASCO Breakthrough is your chance to contribute to a cancer-free future. Don’t miss out—be part of the breakthrough!
